HopeStage
Back to all studies
RecruitingNCT05623306

Stereo-EEG-guided deep brain stimulation or sham for severe OCD

About this titleRead the official source — NCT05623306
Device studyAges 22–75United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 22 years to 75 years.

Listed locations
Stanford and 1 more locationSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 13, 2023
Recruitment status
Recruiting
Enrollment listed in the registry
12
Sponsor
Casey H. Halpern, M.D.
Sponsor type
Individual investigator
Study type
Device
Intervention type
Device
Locations
United States
Age range
From 22 Years to 75 Years
Official registry ID
NCT05623306
Official title
Show the full official title

A Double-Blinded, Randomized, Crossover Trial of Stereoencephalography- Guided Multi-Lead Deep Brain Stimulation for Treatment-Refractory Obsessive-Compulsive Disorder (SEEG-Guided DBS for OCD)

Recruitment & locations

Currently recruiting

Stanford · Philadelphia

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Casey H. Halpern, M.D.

Who can participate?

Listed age limits: 22 years to 75 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies